Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Carhart‐Harris, Robin; Bolstridge, Mark; Rucker, James; Day, Camilla; Erritzøe, David; Kaelen, Mendel; Bloomfield, Michael; A. Rickard, James; Forbes, Ben; Feilding, Amanda; Taylor, David; Pilling, Steve; H. Curran, Valerie; Nutt, David

doi:10.1016/s2215-0366(16)30065-7

Public

Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study

Published in The Lancet Psychiatry • May 17, 2016

Authors:

Robin Carhart‐Harris

Mark Bolstridge

James Rucker

Abstract

BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with p...

Subject

Psilocybin

Dosing

Treatment-resistant depression

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!